0% found this document useful (0 votes)
314 views13 pages

Untitled

Top picks include banks as key holdings: Yapi Kredi and Vakifbank plus mid-cap Bank Asya. Lower mortgage rates and a rebounding economy make us OW Emlak. We take profit and remove Emaar from The CEEMEA Strategy Top 10 list.

Uploaded by

api-167354334
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
314 views13 pages

Untitled

Top picks include banks as key holdings: Yapi Kredi and Vakifbank plus mid-cap Bank Asya. Lower mortgage rates and a rebounding economy make us OW Emlak. We take profit and remove Emaar from The CEEMEA Strategy Top 10 list.

Uploaded by

api-167354334
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

CEEMEA Equity Research

05 February 2013

Reiterating OW on Turkey after 10% drop


If you wanted a pull-back, this is it. Re-load banks, real estate and Turkcell
We reiterate our OW on Turkey after the 9% drop last week on MSCI Turkey and 10% on the ISE futures. If you were waiting for a pullback to get in, this is it. Our top picks include banks as key holdings: Yapi Kredi and Vakifbank plus mid-cap Bank Asya. Lower mortgage rates and a rebounding economy make us OW Emlak. Autos and white good could also perform. We think there are significant upside catalysts in Turkcell coming with the possible exit of Alfa and resumption of dividends. We were surprised by the big drop in Turkish stocks given the nonreaction by FX and bond yields we see few if any changes in the macro outlook. We think valuations in Turkey remain fair, not expensive in a historical context on a forward PE basis, stocks remain within 1 standard deviation of the long-term average. Lower bond yields make us believe that valuations should trade expensive. Moreover, we find no compelling OW markets in the rest of MSCI EMEA. We take profit and remove Emaar from the CEEMEA Strategy Top 10 list. We added Emaar on 9 Jan at AED4.1. Now, we are up 15% in 3 weeks. In its place we add Sberbank. Oil prices are rising, the global cycle is accelerating a little more Russia makes a lot of sense. Sberbank is guiding '13 net income well above consensus forecasts, if in line with our own. We are happy to stay OW financial (30% of the index but half our list). It beat the index 14 of the last 15 months and benefits from the lowest-for-longest period of EM rates. The CEEMEA Strategy Top 10 list is up 4.3% YTD and beating the index by 357 bps YTD after outperforming by 22.1% in 2012.
Table 1: CEEMEA Strategy Top 10 Stock Picks
Name Ticker Country Sector Analyst Price 25-Jan Mkt Cap USD m % YTD USD JPM Rating JPM PT EPS 12 E 13E P/E Ratio 12E 13E

CEEMEA Equity Strategy David Aserkoff, CFA


AC

(44-20) 7134-5887 [email protected] J.P. Morgan Securities plc

Saharsh Kumar
(91-22) 6157-3271 [email protected] J.P. Morgan India Private Limited

Magnit Rosneft Sberbak Naspers Ltd MTN Turkcell Yapi Kredi Emlak Konut PZU Samba

MGNT LI ROSN LI SBER RX NPN SJ MTN SJ TCELL TI YKBNK TI EKGYO TI PZU PW SAMBA AB

Russia Russia Russia S.Africa S.Africa Turkey Turkey Turkey Poland Saudi

Staples Energy Financials Cons. Discr Telecoms Telecoms Financials Financials Financials Financials

Jouronova Gromadin Kantarovich Joosub Lemardeley Lemardeley Formanko Hasan Huttner Bilandani

46.1 8.78 108.47 57,810 17,594 10.8 5.3 3.2 407.8 45.2

21,867 92,098 77,573 27,251 37,546 13,659 13,173 4,528 11,461 10,823

15.0 -1.5 18.7 2.1 -5.0 -4.5 3.7 4.8 -5.7 1.1

OW OW OW OW OW OW OW OW OW OW

43.0 10.6 136.4 68630 18500 15.0 5.7 3.1 430 63

1.65 1.29 0.50 1850 1139 0.50 0.44 0.17 36.5 4.88

1.83 1.56 0.56 2141 1420 0.55 0.55 0.13 34.8 5.71

27.9 6.8 6.9 31.2 15.4 12.7 12.0 12.1 11.2 9.3

25.2 5.6 6.1 27.0 12.4 11.7 9.6 11.2 11.7 7.9

Source: J.P. Morgan estimates, Bloomberg, Updated as of cob 1 February 2013.

See page 10 for analyst certification and important disclosures, including non-US analyst disclosures.
J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. www.jpmorganmarkets.com

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Stocks moved but FX and bonds did not


We reiterate our OW on Turkey after the 9.4% drop from the intra-day high on 24 Jan to the 31 Jan intra-day low on the ISE 100. The ISE futures were down more than 10%. And MSCI Turkey was -8.9%. If you were waiting for a pullback to get in, we think this is it. We are happy with banks as key holdings: Yapi Kredi and Vakifbank plus mid-cap Bank Asya. Lower mortgage rates and a rebounding economy make us OW Emlak. Autos and white goods could also perform well in 13 as the economy picks up and rates stay low. We think there are significant upside catalysts in Turkcell coming with the possible exit of Alfa and resumption of dividends. We were surprised by the big drop in Turkish stocks given the non-reaction by FX and bond yields we do not see any change in the macro outlook. We think valuations in Turkey remain fair, not expensive in a historical context while lower bond yields make us believe that valuations should trade expensive. Moreover, we find few compelling OWs in the rest of CEEMEA weightings are all relative. We find macro reasons for the big correction, well, hard to find. Turkey went through 2012 without a 10%/3 week drawdown on the ISE futures. We would normally see a big drop in the currency during such a equity pull-back looking at each time we have seen a 8% drop in MSCI Turkey in 3 weeks or less, on average, we have seen a 4.2% weakening in TRY (about 7 points). But now, we have seen a 0.3% weakening, rounding error, really. On average, we would see a 26 bp back up in yields, this time we have see a 3 bp move again rounding error. The two key macro risks that we see facing the stock market are: a) the current account deficit and b) the threat of higher reserve requirement ratios (RRR) on the bank sector. First on the CAD, our economist is forecasting a slightly wider deficit in '13 from '12 (US$60.4b or 6.7% from US$52.9 bn or 6.6%). Bears on Turkey argue that faster GDP growth this year (we forecast 37% from 2.6%) will push the deficit significantly wider. The problem for equity bulls is we can not disprove the bear case until the economy picks up steam.
Figure 1: ISE 100
90,000 85,000 80,000 75,000 70,000 65,000 60,000 55,000 50,000 Jan-12

Apr-12 ISE 100

Jul-12

Oct-12 50 day MA

Jan-13

Source: J.P. Morgan, Bloomberg, cob 1 Feb 2013

Figure 2: Turkey equity vol up v FX vol down

Source: J.P. Morgan, Bloomberg, cob 1 Feb 2013

Figure 3: Lira and 2 year bond yields in the last year


10.5 9.5 8.5 1.8 7.5 6.5 5.5 Feb-12 May-12 Aug-12 Nov-12 TRY Spot (RHS) 1.75 1.7 2 year Benchmark Yield (RHS)
Source: J.P. Morgan, Bloomberg, cob 1 Feb 2013

1.9 1.85

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Valuations still reasonable


Second, on the potential for the CBRT to raise RRR. Higher RRRs would be designed to limit loan growth and the CAD and would be done instead of raising rates (which would draw in carry traders and push up the TRY). We think the knee-jerk reaction would be to sell bank stocks their NIMs would be hit by the need to deposit additional reserves yielding zero. But, we think the impact on the lending market would be significantly positive less competition for loans and, at the margin, better asset pricing. We can not argue the stock market is cheap in absolute terms any more. But it doesn't appear very expensive either. PE's are only 17% above the long-term average, less than one standard deviation. Investors could also buy into the macro problems in South Africa on a 15% premium to its historical average. But Turkeys equity yield/bond yield is at a massive 23% discount vs. its long-term average. This reminds us a lot of the mid-90's convergence stock markets in Southern Europe where rates which historically had been 15%ish moved to 5%ish as the region entered EMU. We expect Turkish savers to move from bonds/money markets into equities. This process started in 2006-7 but reversed in the GFC and should resume, aided by Turkeys new pension fund law. Of all the CEEMEA markets, we think Turkey newly low rates, strong GDP and profit growth is the most likely to trade at a significant premium to old notions of fair value. And the lower beta vs. EM (see Figure 4) also supports higher multiples vs. GEMs (see Figure 5).
Figure 4: Turkeys downward trending beta vs. EM
2.0 1.5 1.0 0.5
Source: J.P. Morgan, MSCI, I/B/E/S, Datastream, Bloomberg, cob 1 February 2013

Figure 5: Turkeys re-rating vs. GEMs


4 2 0 -2 -4 -6 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11

Turkey-GEM's 12m Fwd PE


Source: J. P. Morgan research, I/B/E/S, cob 1 February 2013

Figure 6: A long-term look at forward PEs


12M Fwd PE Avg Turkey -1sd +1sd

14 12 10 8 6 4 Jan-03

Jan-05

Jan-07

Jan-09

Jan-11

Jan-13

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Figure 7: Earnings Yield/ Bond Yield stocks still cheap

0.0 Jan-08

Jan-09

Jan-10

Jan-11

Jan-12 Trendline

Jan-13

6M Rolling Beta: Turkey v EM


Source: J.P. Morgan, Bloomberg.

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

JPM Turkey Coverage and MSCI performance by stock


Table 2: JPM coverage of Turkey stocks
Name Akbank Anadolu Efes Bank Asya BIM Coca-Cola Icecek Emlak Konut Garanti Halkbank Isbank Koza Gold Migros Ticaret Petkim Turk Telekom Turkcell lker Vakifbank Yapi Kredi Share Price (TRY) 9.16 25.8 2.25 87.25 41.5 3.2 9.08 18.15 6.66 44.3 20.8 3.11 7.44 10.8 10.35 5.38 5.28 Price Target (TRY) 8.8 27.0 3.0 54.4 45.0 3.1 9.6 21.2 6.9 58.6 20.5 1.7 9.0 15.0 8.4 5.5 5.7 Upside to Target (%) -3.9 4.7 33.3 -37.7 8.4 -3.1 5.7 16.8 3.6 32.3 -1.6 -45.0 21.0 38.9 -18.8 2.2 8.0 BBG Code AKBNK TI AEFES TI ASYAB TI BIMAS TI CCOLA TI EKGYO TI GARAN TI HALKB TI ISCTR TI KOZAL TI MGROS TI PETKM TI TTKOM TI TCELL TI ULKER TI VAKBN TI YKBNK TI Rating UW N OW N OW OW N OW N OW N UW OW OW N OW OW Mkt Cap, US$ MM 20,870 8,836 1,164 7,609 6,056 4,528 21,818 13,065 17,168 3,909 2,119 1,794 15,112 13,659 1,997 7,804 13,173 P/E (X) 12E 13E 16.1 12.2 22.4 20.7 10.4 8.7 37.4 32.1 27.1 22.5 18.4 24.3 12.4 11.2 10.9 9.8 11.6 10.6 0.0 0.0 14.0 24.8 -105.1 23.5 9.5 9.3 11.5 10.5 19.1 18.7 11.5 9.9 13.0 7.9 EPS (LC) 12E 13E 0.62 0.83 1.15 1.25 0.25 0.29 2.33 2.72 1.53 1.84 0.17 0.13 0.81 0.89 1.83 2.05 0.64 0.70 0.00 0.00 1.49 0.84 -0.03 0.13 0.78 0.80 0.53 0.59 0.54 0.55 0.52 0.60 0.44 0.73 Yield (%) 13E (%) 3.0 2.4 0.0 3.6 1.6 0.0 3.7 4.0 3.5 2.2 0.0 3.3 10.1 0.0 0.0 0.0 0.0 ROE (%) 13E 15.4 22.6 10.5 47.9 25.2 7.7 17.6 21.7 14.7 44.8 0.0 7.7 42.0 0.0 17.9 12.9 14.8

Source: J. P. Morgan research, Bloomberg, Price as cob 1 February

Table 3: MSCI Turkey Performance by stocks


Name Turkcell Akbank Bank Asya Tofas-Turk Otomotiv Turk Hava Yollar Isbank Garanti Bank Halk Bank Koc Hldg Yapi Kredi Emlak Konut Enka Insaat Ford Otomotiv Sabanci Holding Turk Sise Cam Vakifbank Anadolu Efes Eregli Demir Koza Gold Tupras Turk Telekom. BIM Birlesik Coca-Cola Icecek Arcelik TAV Havalimanlar Performance in 2012 37% 54% 47% 86% 212% 97% 66% 87% 81% 104% 69% 53% 48% 92% 21% 99% 19% 13% 81% 36% 4% 76% 73% 102% 20% YTD till 24th Jan 2013 7% 17% 16% 13% 17% 20% 9% 14% 12% 11% 10% 9% 3% 11% 18% 25% 7% 8% 10% 1% 13% 4% 15% 6% 17% Returns since 24th Jan 2013 -11% -10% -10% -9% -9% -9% -8% -7% -6% -6% -5% -5% -5% -5% -5% -5% -4% -4% -4% -3% -3% -2% -1% 0% 4%

Source: J. P. Morgan research, Bloomberg, Price as cob 1 February

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

IS OW Turkey a dangerously consensus call? No, its our favorite CEEMEA market
One of the other bear points is that being OW Turkey is consensus this is becoming a crowded trade. As 4Q12 began, we would argue strenuously against this notion. Now, we can disagree and change the subject. Foreign equity holdings (see Figure 8) are clearly up from their lows. But, they are still well below their 2011 peaks. And still well below their 2007-8 peaks. Moreover, Turkey generates little interest from global accounts that would feel comfortable trading in BRICs but not the smaller EM markets. We must acknowledge that the EPFR data show Turkey to be one of the most popular EM markets (see our report, Consensus Asset Allocation: EM funds asset allocation and performance dated 27 Jan). Only Russia has a bigger overweight position in terms of asset allocation of the median fund manager and Turkey is the most popular in terms of the number of funds more than 2% OW versus the benchmark. And the monthly inflow data show second straight months in the black. Still, we focus on the complete set of data from the Central Depository of Securities that show foreign ownership, rather than a survey of only a selected group of funds. One key reason that we do not see Turkey as dangerously consensus is that the other CEEMEA markets remain a struggle. The biggest market, South Africa, is hurt by labour strife in the mining sector plus the first round of disappointments from the retailers the market darlings of 2011 and 2012. Russia, the second biggest market, has been the cheapest GEM market since 2008 yet is the biggest consensus OW in terms of the median funds positive versus the benchmark. We see few positive catalysts on the policy front. Poland, the 3rd biggest market, is mired in recession. Turkey offers a) the best long-term growth and demographics of any major market in region; b) the biggest 2013 GDP growth pick up and c) the best EPS revision over the last three months.
Figure 8: Foreign holdings still below 2011 peak
74 72 70 68 66 64 62 60 Jan-07 Jan-08 Jan-09 Jan-10 Jan-11 Jan-12 Jan-13 Foreign ownership as % of the free float

Source: Central Depository of Securities, 21 January 2013

Figure 9: Foreign ownership of TRY bonds


70 60 50 40 30 20 10 Jan-08 Jan-09 Jan-10 Jan-11 Jan-12 Jan-13 3a-TL and FX indexed in USD bn

Source: CBRT, 25 January 2013

Figure 10: Monthly flows to MSCI Turkey and Banks


1,000 800 600 400 200 0 (200) (400) (600) (800) Aug-11 Dec-11 Apr-12 Aug-12 Banks Dec-12 MSCI Turkey
Source: CBRT, 31 December 2012

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

CEEMEA Strategy Top 10 list


We take profit and remove Emaar from the CEEMEA Strategy Top 10 list. We added Emaar on 9 Jan at AED4.14. Now, we are up 15% in 3 weeks. Our thesis is that the strong Dubai economy and high-quality cash flows in the Dubai Mall are not priced into the stock below book value. Our analyst, Muneez Hasan, has a AED 5.35 target. While it is out of our top 10 list, we would still be very happy to hold it in a broader CEEMEA (or GEM or global) portfolio. In its place we add Sberbank. We have had two Russian stocks in the CEEMEA Strategy Top 10 list since April 12 much less than the 35% weight in MSCI EMEA. Oil prices are rising, the global cycle is accelerating a little more Russia makes a lot of sense. Sberbank is guiding '13 net income well above consensus forecasts, if in line with our own. If our banks analyst, Alex Kantarovich, stays right on Sberbank earnings (and he has been above consensus for 2+ years while consensus has risen), then the stock has upside. Russian financials historically have outperformed oils when crude prices rise. And earnings revisions remain a key theme for us in GEM and CEEMEA strategy for 2013. Swapping out real estate for a bank leaves us still with half the CEEMEA Strategy Top 10 list in financials (30% of the index) we are happy to be OW. It has beat the index 14 of the last 15 months and benefits from the lowest-for-longest period of EM rates. The CEEMEA Strategy Top 10 list is up 4.3% YTD and beating the index by 357 bps YTD after outperforming by 22.1% in 2012.

Table 4: CEEMEA Strategy top 10 - Performance and composition history


Portfolio Performance: Benchmark Performance: Portfolio v Benchmark Start date End date Entrants Exits Period Cumulative Period Cumulative Period Cumulative Portfolio as on 12th Feb 2012 (Top 10 CEEMEA Picks) - Sberbank, Gazprom, Lukoil, AFK Sistema, Halkbank, Yapi Kredi, Woolworths, PZU, SABIC, Emaar 12-Feb-12 23-Mar-12 4.5% 4.5% 1.9% 1.9% 2.6% 2.6% 23-Mar-12 20-Apr-12 Garanti Halkbank, Yapi Kredi -0.5% 3.9% -1.9% 0.0% 1.4% 4.0% 20-Apr-12 11-May-12 ABSA, Aspen, Lukoil, AFK Sistema, -4.3% -0.5% -5.3% -5.3% 1.1% 5.1% Naspers, Mr. Price Emaar 11-May-12 18-Jun-12 Erste Bank PZU -4.9% -5.4% -2.1% -7.3% -2.9% 2.1% 18-Jun-12 3-Aug-12 Halkbank, ABSA 12.3% 6.3% 5.9% -1.9% 6.1% 8.3% Koc Holding SABIC 3 Aug 12 31-Aug-12 MTN Group, Mr Price, Halkbank 3.0% 9.5% -1.4% -3.3% 4.5% 13.2% Yapi Kredi 31-Aug-12 7-Sep-12 Woolworths 3.4% 13.2% 4.6% 1.2% -1.2% 11.9% 7-Sep-12 5-Oct-12 PZU 0.9% 14.2% -0.8% 0.4% 1.7% 13.7% 5-Oct-12 26-Oct-12 Rosneft, Turkcell, Gazprom, Garanti, 1.4% 15.9% -1.0% -0.6% 2.5% 16.6% Samba Aspen 26-Oct-12 13-Nov-12 Sasol MTN 1.8% 18.0% -1.3% -1.9% 3.2% 20.3% 13-Nov-12 31 Dec 12 Emlak, Magnit Sberbank,Koc Holding 10.8% 30.8% 9.1% 7.1% 1.5% 22.1% 2012 Summary 30.8% 7.1% 22.1% 31 Dec 12 11 Jan 13 1.6% 32.9% 0.4% 7.4% 1.3% 23.7% 11 Jan 13 25 Jan 13 MTN, Emaar Sasol, Erste Bank 2.6% 36.4% 0.3% 7.8% 2.3% 26.5% Properties 1 Feb 13 Sberbank Emaar Properties
Source: J.P. Morgan research, Bloomberg, updated cob 1 Feb 2013. Note: Benchmark is MSCI EMEA. Past results cannot and should not be viewed as an indicator of future performance. Transaction and other costs have not been included in these calculations. Full details of the calculation and historical comparisons are available.

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Summary: CEEMEA Countries Valuations


1-Feb-13 Hist.** P/ EPS MSCI Index Trough (Trend) EMF EMEA Czech Republic Hungary Poland Russia South Africa Turkey Middle East & Africa Egypt Morocco^ Qatar^ Saudi Arabia UAE^ Nigeria EMF Asia* China India EMF LatAm Mexico Brazil Emerging Markets Japan Europe USA Global Current Trailing P/E (x) 12m Fwd Prospective 2011 2012E 2013E Div. Yield (%) Hist.** Trailing Prospective Hist.** Peak Trailing 2012E 2013E Trough P/BV (x) Current Prospective Trailing 2012E 2013E Earnings growth (%) 2010 2011 2012E 2013E 2011 ROE (%) 2012E 2013E

463 276 1,090 1,725 804 1,007 1,135,120 1,213 290 791 452 259 745 674 66 775 7,622,638 43,068 215,118 47,478 582 1,214 1,446 378

6.3 7.3 3.5 6.5 3.9 9.1 5.1 5.7 12.3 6.8 8.7 -38.6 4.8 10.3 7.2 9.6 8.6 9.0 6.5 10.2 11.5 9.7 11.6 9.4

7.1 5.3 5.3 10.6 3.1 11.7 7.5 4.9 13.8 8.2 15.4 9.9 11.8 7.2 10.6 21.6 10.6 13.7 13.1

8.8 9.4 9.1 10.2 5.6 14.0 11.9 7.3 11.5 12.1 12.6 13.0 10.9 13.0 11.6 16.6 15.6 20.4 13.6 12.6 25.2 12.8 14.9 14.0

8.4 9.7 8.2 11.7 5.7 12.1 10.6 7.3 12.5 10.8 11.4 11.6 9.4 11.3 10.6 14.4 13.0 18.0 11.1 10.9 18.2 11.8 13.7 12.6

8.5 9.3 7.6 9.5 5.1 15.5 13.8 10.9 14.0 13.8 19.0 10.3 12.5 13.2 11.4 18.7 14.2 28.5 11.0 12.8 NM 12.4 16.0 14.6

8.8 9.4 9.2 10.1 5.6 14.3 12.0 7.3 11.5 12.2 12.7 13.1 11.1 13.2 11.7 16.8 15.9 20.7 13.9 12.7 26.1 12.9 15.0 14.1

8.4 9.7 8.3 11.8 5.7 12.2 10.7 7.4 12.0 10.9 11.5 11.7 9.4 11.4 10.7 14.6 13.1 18.2 11.2 11.0 18.8 11.9 13.9 12.8

4.9 10.0 5.3 7.1 4.0 4.7 4.0 9.2 5.8 9.7 7.0 7.5 12.2 3.4 5.7 2.6 5.1 4.1 7.6 3.6 3.0 6.1 4.0 4.1

3.7 7.8 4.0 5.5 3.8 3.3 2.7 3.9 4.7 4.6 4.2 3.1 4.9 2.4 2.8 1.5 2.8 1.6 3.4 2.8 2.1 3.5 2.1 2.7

3.6 7.8 3.9 5.6 3.8 3.3 2.6 3.9 4.8 4.5 4.1 3.0 4.9 2.4 2.8 1.5 2.8 1.6 3.3 2.8 2.0 3.5 2.1 2.6

3.9 7.9 4.5 4.7 4.1 3.8 3.0 4.3 5.0 4.8 4.8 3.4 5.8 2.5 3.0 1.6 3.0 1.7 3.8 2.9 2.2 3.8 2.3 2.8

1.2 0.5 0.6 1.0 0.2 1.4 1.4 1.0 2.8 1.3 1.3 0.5 0.8 1.0 0.5 1.4 0.6 0.7 0.4 1.0 0.9 1.1 1.4 1.3

1.3 1.5 0.9 1.3 0.8 2.3 1.8 0.9 2.1 1.8 1.9 1.1 2.7 1.7 1.7 2.6 1.7 2.1 1.4 1.6 1.2 1.6 2.0 1.7

1.3 1.5 0.9 1.3 0.8 2.3 1.8 0.9 2.4 1.8 1.8 1.1 2.6 1.7 1.7 2.6 1.7 2.1 1.5 1.6 1.2 1.6 2.0 1.7

1.2 1.4 0.8 1.2 0.8 2.1 1.7 0.8 2.5 1.7 1.7 1.0 2.3 1.5 1.5 2.3 1.6 1.9 1.4 1.5 1.1 1.5 2.0 1.7

31.5 -1.3 7.4 34.4 42.7 25.2 18.0 -2.3 -9.4 11.2 51.9 -53.6 -24.4 37.3 34.3 23.0 23.9 -7.9 29.1 33.0 NM 38.9 47.7 33.9

28.0 -12.4 23.6 26.4 39.5 20.5 -5.9 21.3 1.7 4.6 na 53.6 9.7 -4.1 10.8 7.0 -0.9 -0.9 -2.5 3.3 51.1 2.3 15.3 8.0

-3.2 -0.9 -18.1 -6.2 -9.1 9.0 15.1 48.4 -5.9 12.1 67.4 14.5 163.9 4.9 -2.1 11.6 -11.0 37.8 -20.8 0.3 -27.4 -3.8 6.7 3.3

4.1 -2.8 10.7 -14.4 -1.7 16.8 11.5 -1.4 -4.1 12.3 10.3 11.8 17.3 15.0 9.4 14.9 21.3 13.5 24.5 15.6 38.6 8.7 8.0 10.7

18.2 16.9 13.8 15.3 19.0 17.8 16.3 13.6 30.7 12.9 6.8 17.6 14.4 17.7 17.0 13.0 13.7 13.0 14.1 6.3 13.0 15.3 13.2

15.7 16.2 10.0 13.1 15.6 17.3 16.7 14.9 28.1 14.8 14.5 8.1 37.6 13.6 15.5 16.5 10.7 12.4 10.1 12.9 4.5 12.5 14.4 12.7

14.8 15.1 10.2 10.7 14.0 18.2 16.2 11.5 29.0 15.3 14.9 8.4 38.6 14.2 15.2 16.5 12.4 11.1 12.6 14.0 6.0 13.1 14.3 13.1

Source: I/B/E/S, MSCI, Bloomberg, J.P. Morgan estimates.

Updated as of cob 1 Feb 2013

* Market forecast numbers are derived from bottom-up calculations of each individual MSCI constituents using JP Morgan estimates for covered stocks and I/B/E/S estimates for the rest. ^ Market forecast numbers are Bloomberg Estimates for Generic Years (1 and 2) for each MSCI index. For all other markets, forecast numbers are derived from bottom-up calculations of each individual MSCI constituents using I/B/E/S estimates. Hist. ** refers to the historically lowest valuation of the MSCI indices since last 5 years. Trough PE represents the lowest 12 month trailing PE. For dividend yield the highest values are taken to represent the best multiple. USA, Europe and Japan PE are I/B/E/S aggregate estimates. Japan Valuation estimates are for the financial year ending March P / EPS (Trend) uses the trend EPS for the indices calculated by the linear regression on the natural log of trailing EPS. For more, please refer to 'Mayday call for the shorts - Perspectives and Portfolios', 5 May 2009, Mowat et al. P / EPE (Trend)' is NM for indices where the modeled relationship is weak with a less than 0.50 R-square. The start dates China and Singapore models are modified to make them more relevant. Sector indices inputs have not been altered.

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

CEEMEA Price Earnings (12m forward EPS)


Figure 11: MSCI EM 12m Forward PE
15 14 13 12 11 10 9 8 7 6 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11 Jan-13 4 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11 Jan-13 12 10 8 6
12M Fwd PE Avg EM -1sd +1sd

Figure 14: MSCI EMEA 12m Forward PE


14
12M Fwd PE Avg EMEA -1sd +1sd

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Figure 12: MSCI Turkey 12m Forward PE


12M Fwd PE Avg Turkey -1sd +1sd

Figure 15: MSCI Poland 12m Forward PE


18 16 14 12 10 8 6 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11 Jan-13
12M Fwd PE Avg Poland -1sd +1sd

14 12 10 8 6 4 Jan-03

Jan-05

Jan-07

Jan-09

Jan-11

Jan-13

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Figure 13: MSCI Russia 12m Forward PE


14 12 10 8 6 4 2 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11 Jan-13
12M Fwd PE Avg Russia -1sd +1sd

Figure 16: MSCI South Africa 12m Forward PE


13 12 11 10 9 8 7 6 Jan-03 Jan-05 Jan-07 Jan-09 Jan-11 Jan-13
12M Fwd PE Avg South Africa -1sd +1sd

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

Source: IBES, Datastream, Bloomberg, cob 1 Feb 2013

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

CEEMEA Market Performance: MSCI Performance by Countries and Sectors


EM Eastern Europe EMF Latin America North America EM Europe EMF Asia Europe Mexico
Year To Date

Consumer Discretionary Consumer Staples Energy Financials Healthcare Industrials Information Technology Materials Telecoms Utilities Region / Country Benchmark Change vs dollar

5.8% 5.9% 6.2% 6.5% 7.8% 5.2% 2.5% 2.8% 4.2% 2.4% 5.3%

6.3% 6.3% 7.8% 6.4% 8.2% 7.0% 2.9% 2.3% 4.0% 4.9% 5.9%

7.6% 6.8% 4.9% 9.2% 7.6% 6.6% 10.5% 4.8% 7.2% 0.1% 6.9%

13.3% 12.5% 11.5% 9.2% 16.9% 6.8% 6.3% 9.8% 9.7% -1.9% 9.7%

-1.2% 2.0% 1.9% 4.9% -0.5% 0.7% -1.1% 0.1% 0.6% 3.4% 1.7%

-4.5% -3.1% 2.9% 3.2% -8.1% -0.6% 1.4% -1.4% -0.7% -0.6% 0.7%

3.5% 9.7% 3.1% 7.4% 7.2% 1.4% 3.9% 4.6% -0.6% 4.9%

3.9% 14.2% 3.2% 8.8%

1.4% 3.8% 6.1% -0.6% 5.0%

6.5% 7.0% 0.7% 5.0% 3.5% 7.9% 5.7% 1.7% 10.4% 5.5% 4.8%

-2.0% -1.3% 1.7% 5.4% 1.5% -0.8% -1.2% -0.7% -2.6% 3.3% 0.9% 0.0%

-0.9% 5.0% -3.4% 2.3% 0.3% 4.7% 2.5% -3.1% 3.8% 1.3% 0.6% 3.2%

5.8% 1.5% 0.0% 8.2% -1.0% 4.4% 9.5% 5.0% -4.6% 11.5% 4.4% 0.1%

-3.8% -1.1% 8.1% -1.4% 0.1% -4.0% 13.4% -4.7% 5.6% -3.3% 1.4% 3.4%

-3.2% -6.5% -4.4% 5.3% 0.5% -3.5% -4.6% -3.1% 7.1% 5.5% -2.6% -3.0%

7.7% 3.0% -0.2% 6.6% 3.7% 9.0% 4.7% 2.5%

0.3% -0.2% -0.9% 4.9% -0.6% 4.2% 1.3% 3.1% -0.7% 2.0% -1.9%

EMEA(Europe & Middle East)

Czech Republic

South Africa

Hungary

Poland

Russia

Year To Date

Consumer Discretionary Consumer Staples Energy Financials Healthcare Industrials Information Technology Materials Telecoms Utilities Region / Country Benchmark Change vs dollar
Source: Bloomberg, MSCI.

3.5% 9.7% 3.1% 7.4% 7.2% 1.4% 3.9% 4.6% -0.6% 4.9%

-5.5%

1.6% 2.6%

4.5% 11.7%

2.1% 8.1% 2.1% -6.1% -0.4% -0.5% -1.9% -4.7% -2.8% 1.3%

12.5% 0.8% 15.2%

-0.9% -11.7% 6.1% 1.8% -4.0% -0.4% -0.6% -0.9% -0.4% -4.1%

1.3% 1.8% -3.9% 2.9% 5.1% 2.2% -2.4% 2.1% 2.0%

0.7% -9.7% -6.6% 1.0%

8.5% 3.3% -5.2%

10.4% 8.7% 3.0%

2.7% 4.8% 4.6% 4.5% 2.2%

Updated as of cob 1 February 2013

Note: Local currency movements against the dollar: appreciation / (depreciation).Country and sector cross sections in italic blue have outperformed their indices by more than 2%. Cross sections in red have underperformed their indices by more than 2%. 9

Turkey

Egypt

Taiwan

Global

EMEA

Japan

Korea

China

Brazil

India

EMF

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Analyst Certification: The research analyst(s) denoted by an AC on the cover of this report certifies (or, where multiple research analysts are primarily responsible for this report, the research analyst denoted by an AC on the cover or within the document individually certifies, with respect to each security or issuer that the research analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s) in this report.

Important Disclosures

Market Maker/ Liquidity Provider: J.P. Morgan Securities plc and/or an affiliate is a market maker and/or liquidity provider in Magnit, Rosneft, Naspers Ltd, MTN Group Limited, Turkcell, Yapi Kredi, Emlak Konut, PZU, Emaar Properties, Samba Financial Group, Vakifbank, Sberbank, VTB, Erste Bank, Bank Asya, Bank Millennium, Coronation Fund Managers Ltd, OTP Bank, Commercial International Bank (Egypt), Magnit, Dixy Group, Eurocash, Medi-Clinic, Netcare Limited.

Lead or Co-manager: J.P. Morgan acted as lead or co-manager in a public offering of equity and/or debt securities for Rosneft, Yapi Kredi, Vakifbank, Sberbank, VTB, Erste Bank within the past 12 months. Client: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as clients: Magnit, Rosneft, Naspers Ltd, MTN Group Limited, Turkcell, Yapi Kredi, PZU, Emaar Properties, Samba Financial Group, Vakifbank, Sberbank, VTB, Erste Bank, Bank Asya, Bank Millennium, Coronation Fund Managers Ltd, OTP Bank, Commercial International Bank (Egypt), Magnit, Dixy Group, Eurocash, Medi-Clinic, Netcare Limited.

Client/Investment Banking: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as investment banking clients: Rosneft, Yapi Kredi, Emaar Properties, Vakifbank, Sberbank, VTB, Erste Bank. Client/Non-Investment Banking, Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as clients, and the services provided were non-investment-banking, securities-related: Magnit, Rosneft, Naspers Ltd, Turkcell, Yapi Kredi, PZU, Samba Financial Group, Vakifbank, Sberbank, VTB, Erste Bank, Bank Asya, Bank Millennium, Coronation Fund Managers Ltd, OTP Bank, Commercial International Bank (Egypt), Magnit.

Client/Non-Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as clients, and the services provided were non-securities-related: Rosneft, Naspers Ltd, Yapi Kredi, Vakifbank, Sberbank, VTB, Bank Asya, Bank Millennium, OTP Bank. Investment Banking (past 12 months): J.P. Morgan received in the past 12 months compensation for investment banking Rosneft, Yapi Kredi, Emaar Properties, Vakifbank, Sberbank, VTB, Erste Bank. Investment Banking (next 3 months): J.P. Morgan expects to receive, or intends to seek, compensation for investment banking services in the next three months from Rosneft, Naspers Ltd, Yapi Kredi, PZU, Emaar Properties, Vakifbank, Sberbank, VTB, Erste Bank. Non-Investment Banking Compensation: J.P. Morgan has received compensation in the past 12 months for products or services other than investment banking from Magnit, Rosneft, Naspers Ltd, Turkcell, Yapi Kredi, PZU, Samba Financial Group, Vakifbank, Sberbank, VTB, Erste Bank, Bank Asya, Bank Millennium, Coronation Fund Managers Ltd, OTP Bank, Commercial International Bank (Egypt), Magnit.

MSCI: The MSCI sourced information is the exclusive property of Morgan Stanley Capital International Inc. (MSCI). Without prior written permission of MSCI, this information and any other MSCI intellectual property may not be reproduced, redisseminated or used to create any financial products, including any indices. This information is provided on an 'as is' basis. The user assumes the entire risk of any use made of this information. MSCI, its affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of this information. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. MSCI, Morgan Stanley Capital International and the MSCI indexes are services marks of MSCI and its affiliates. Company-Specific Disclosures: Important disclosures, including price charts, are available for compendium reports and all J.P. Morgan covered companies by visiting https://mm.jpmorgan.com/disclosures/company, calling 1-800-477-0406, or e-mailing [email protected] with your request. J.P. Morgans Strategy, Technical, and Quantitative Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail [email protected]. Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe: J.P. Morgan uses the following rating system: Overweight [Over the next six to twelve months, we expect this stock will outperform the average total return of the stocks in the analysts (or the analysts teams) coverage universe.] Neutral [Over the next six to twelve months, we expect this stock will perform in line with the average total return of the stocks in the analysts (or the analysts teams)
10

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

coverage universe.] Underweight [Over the next six to twelve months, we expect this stock will underperform the average total return of the stocks in the analysts (or the analysts teams) coverage universe.] Not Rated (NR): J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-Australia) and U.K. small- and mid-cap equity research, each stocks expected total return is compared to the expected total return of a benchmark country market index, not to those analysts coverage universe. If it does not appear in the Important Disclosures section of this report, the certifying analysts coverage universe can be found on J.P. Morgans research website, www.jpmorganmarkets.com. J.P. Morgan Equity Research Ratings Distribution, as of January 1, 2013
Overweight (buy) 44% 53% 42% 71% Neutral (hold) 44% 46% 49% 62% Underweight (sell) 12% 34% 9% 51%

J.P. Morgan Global Equity Research Coverage IB clients* JPMS Equity Research Coverage IB clients*

*Percentage of investment banking clients in each rating category. For purposes only of FINRA/NYSE ratings distribution rules, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation are not included in the table above.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P. Morgan representative, or email [email protected]. Equity Analysts' Compensation: The equity research analysts responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues. Registration of non-US Analysts: Unless otherwise noted, the non-US analysts listed on the front of this report are employees of non-US affiliates of JPMS, are not registered/qualified as research analysts under NASD/NYSE rules, may not be associated persons of JPMS, and may not be subject to FINRA Rule 2711 and NYSE Rule 472 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account.

Other Disclosures
J.P. Morgan ("JPM") is the global brand name for J.P. Morgan Securities LLC ("JPMS") and its affiliates worldwide. J.P. Morgan Cazenove is a marketing name for the U.K. investment banking businesses and EMEA cash equities and equity research businesses of JPMorgan Chase & Co. and its subsidiaries. All research reports made available to clients are simultaneously available on our client website, J.P. Morgan Markets. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your sales representative. Options related research: If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options, please contact your J.P. Morgan Representative or visit the OCC's website at http://www.optionsclearing.com/publications/risks/riskstoc.pdf Legal Entities Disclosures U.S.: JPMS is a member of NYSE, FINRA, SIPC and the NFA. JPMorgan Chase Bank, N.A. is a member of FDIC and is authorized and regulated in the UK by the Financial Services Authority. U.K.: J.P. Morgan Securities plc (JPMS plc) is a member of the London Stock Exchange and is authorized and regulated by the Financial Services Authority. Registered in England & Wales No. 2711006. Registered Office 25 Bank Street, London, E14 5JP. South Africa: J.P. Morgan Equities South Africa Proprietary Limited is a member of the Johannesburg Securities Exchange and is regulated by the Financial Services Board. Hong Kong: J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong. Korea: J.P. Morgan Securities (Far East) Ltd, Seoul Branch, is regulated by the Korea Financial Supervisory Service. Australia: J.P. Morgan Australia Limited (JPMAL) (ABN 52 002 888 011/AFS Licence No: 238188) is regulated by ASIC and J.P. Morgan Securities Australia Limited (JPMSAL) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by ASIC and is a Market, Clearing and Settlement Participant of ASX Limited and CHI-X. Taiwan: J.P.Morgan Securities (Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. India: J.P. Morgan India Private Limited, having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz East, Mumbai - 400098, is a member of the National Stock Exchange of India Limited (SEBI Registration Number - INB 230675231/INF 230675231/INE 230675231) and Bombay Stock Exchange Limited (SEBI Registration Number - INB 010675237/INF 010675237) and is regulated by Securities and Exchange Board of India. Thailand: JPMorgan Securities (Thailand) Limited is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and Exchange Commission. Indonesia: PT J.P. Morgan Securities Indonesia is a member of the Indonesia Stock Exchange and is regulated by the BAPEPAM LK. Philippines: J.P. Morgan Securities Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Brazil: Banco J.P. Morgan S.A. is regulated by the Comissao de
11

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Mexico: J.P. Morgan Casa de Bolsa, S.A. de C.V., J.P. Morgan Grupo Financiero is a member of the Mexican Stock Exchange and authorized to act as a broker dealer by the National Banking and Securities Exchange Commission. Singapore: This material is issued and distributed in Singapore by J.P. Morgan Securities Singapore Private Limited (JPMSS) [MICA (P) 088/04/2012 and Co. Reg. No.: 199405335R] which is a member of the Singapore Exchange Securities Trading Limited and is regulated by the Monetary Authority of Singapore (MAS) and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore) which is regulated by the MAS. Malaysia: This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bursa Malaysia Berhad and a holder of Capital Markets Services License issued by the Securities Commission in Malaysia. Pakistan: J. P. Morgan Pakistan Broking (Pvt.) Ltd is a member of the Karachi Stock Exchange and regulated by the Securities and Exchange Commission of Pakistan. Saudi Arabia: J.P. Morgan Saudi Arabia Ltd. is authorized by the Capital Market Authority of the Kingdom of Saudi Arabia (CMA) to carry out dealing as an agent, arranging, advising and custody, with respect to securities business under licence number 35-07079 and its registered address is at 8th Floor, Al-Faisaliyah Tower, King Fahad Road, P.O. Box 51907, Riyadh 11553, Kingdom of Saudi Arabia. Dubai: JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - Building 3, Level 7, PO Box 506551, Dubai, UAE. Country and Region Specific Disclosures U.K. and European Economic Area (EEA): Unless specified to the contrary, issued and approved for distribution in the U.K. and the EEA by JPMS plc. Investment research issued by JPMS plc has been prepared in accordance with JPMS plc's policies for managing conflicts of interest arising as a result of publication and distribution of investment research. Many European regulators require a firm to establish, implement and maintain such a policy. This report has been issued in the U.K. only to persons of a kind described in Article 19 (5), 38, 47 and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons being referred to as "relevant persons"). This document must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is only available to relevant persons and will be engaged in only with relevant persons. In other EEA countries, the report has been issued to persons regarded as professional investors (or equivalent) in their home jurisdiction. Australia: This material is issued and distributed by JPMSAL in Australia to "wholesale clients" only. JPMSAL does not issue or distribute this material to "retail clients". The recipient of this material must not distribute it to any third party or outside Australia without the prior written consent of JPMSAL. For the purposes of this paragraph the terms "wholesale client" and "retail client" have the meanings given to them in section 761G of the Corporations Act 2001. Germany: This material is distributed in Germany by J.P. Morgan Securities plc, Frankfurt Branch and J.P.Morgan Chase Bank, N.A., Frankfurt Branch which are regulated by the Bundesanstalt fr Finanzdienstleistungsaufsicht. Hong Kong: The 1% ownership disclosure as of the previous month end satisfies the requirements under Paragraph 16.5(a) of the Hong Kong Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission. (For research published within the first ten days of the month, the disclosure may be based on the month end data from two months prior.) J.P. Morgan Broking (Hong Kong) Limited is the liquidity provider/market maker for derivative warrants, callable bull bear contracts and stock options listed on the Stock Exchange of Hong Kong Limited. An updated list can be found on HKEx website: http://www.hkex.com.hk. Japan: There is a risk that a loss may occur due to a change in the price of the shares in the case of share trading, and that a loss may occur due to the exchange rate in the case of foreign share trading. In the case of share trading, JPMorgan Securities Japan Co., Ltd., will be receiving a brokerage fee and consumption tax (shouhizei) calculated by multiplying the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co., Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co., Ltd., Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association, The Financial Futures Association of Japan, Type II Financial Instruments Firms Association and Japan Investment Advisers Association. Korea: This report may have been edited or contributed to from time to time by affiliates of J.P. Morgan Securities (Far East) Ltd, Seoul Branch. Singapore: JPMSS and/or its affiliates may have a holding in any of the securities discussed in this report; for securities where the holding is 1% or greater, the specific holding is disclosed in the Important Disclosures section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the course of and for the purposes of their business, habitually invest money. JPMSAL does not issue or distribute this material to members of "the public" as determined in accordance with section 3 of the Securities Act 1978. The recipient of this material must not distribute it to any third party or outside New Zealand without the prior written consent of JPMSAL. Canada: The information contained herein is not, and under no circumstances is to be construed as, a prospectus, an advertisement, a public offering, an offer to sell securities described herein, or solicitation of an offer to buy securities described herein, in Canada or any province or territory thereof. Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to file a prospectus with the relevant Canadian securities regulators and only by a dealer properly registered under applicable securities laws or, alternatively, pursuant to an exemption from the dealer registration requirement in the relevant province or territory of Canada in which such offer or sale is made. The information contained herein is under no circumstances to be construed as investment advice in any province or territory of Canada and is not tailored to the needs of the recipient. To the extent that the information contained herein references securities of an issuer incorporated, formed or created under the laws of Canada or a province or territory of Canada, any trades in such securities must be conducted through a dealer registered in Canada. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed judgment upon these materials, the information contained herein or the merits of the securities described herein, and any representation to the contrary is an offence. Dubai: This report has been issued to persons regarded as professional clients as defined under the DFSA rules. General: Additional information is available upon request. Information has been obtained from sources believed to be reliable but JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) do not warrant its completeness or accuracy except with respect to any disclosures relative to JPMS and/or its affiliates and the analyst's involvement with the issuer that is the subject of the research. All pricing is as of the close of market for the securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. The recipient of this report must make its own independent decisions regarding any securities or financial instruments mentioned herein. JPMS distributes in the U.S. research published by non-U.S. affiliates and accepts responsibility for its contents. Periodic updates may be provided on companies/industries based on company specific developments or announcements, market conditions or any other publicly available information. Clients should contact analysts and execute transactions through a J.P. Morgan subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise. "Other Disclosures" last revised January 1, 2013.

12

David Aserkoff, CFA (44-20) 7134-5887 [email protected]

CEEMEA Equity Research 05 February 2013

Copyright 2013 JPMorgan Chase & Co. All rights reserved. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. #$J&098$#*P

13

You might also like